$3.27 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 87 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FSRXW | Exit | FINSERV ACQUISITION CORP II*w exp 02/17/202 | $0 | – | -273,149 | -100.0% | -0.00% | – |
| SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -105,744 | -100.0% | -0.01% | – |
| Exit | NUVALENT INC | $0 | – | -200,000 | -100.0% | -0.07% | – | |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -265,116 | -100.0% | -0.08% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INCcall | $0 | – | -367,100 | -100.0% | -0.10% | – |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -851,291 | -100.0% | -0.11% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -410,000 | -100.0% | -0.20% | – | |
| Exit | GRAB HOLDINGS LIMITEDclass a ord | $0 | – | -2,000,000 | -100.0% | -0.28% | – | |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -1,218,792 | -100.0% | -0.38% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -245,800 | -100.0% | -0.44% | – |
| ETSY | Exit | ETSY INC | $0 | – | -122,158 | -100.0% | -0.52% | – |
| KBR | Exit | KBR INC | $0 | – | -685,500 | -100.0% | -0.63% | – |
| Exit | WARBY PARKER INC | $0 | – | -733,402 | -100.0% | -0.66% | – | |
| CPRT | Exit | COPART INC | $0 | – | -305,000 | -100.0% | -0.90% | – |
| Exit | RIVIAN AUTOMOTIVE INC | $0 | – | -507,830 | -100.0% | -1.02% | – | |
| TEL | Exit | TE CONNECTIVITY LTD | $0 | – | -382,623 | -100.0% | -1.20% | – |
| SQ | Exit | BLOCK INCcl a | $0 | – | -429,984 | -100.0% | -1.34% | – |
| ALIT | Exit | ALIGHT INC | $0 | – | -7,810,000 | -100.0% | -1.64% | – |
| OPEN | Exit | OPENDOOR TECHNOLOGIES INC | $0 | – | -6,168,996 | -100.0% | -1.74% | – |
| CVNA | Exit | CARVANA COcl a | $0 | – | -427,807 | -100.0% | -1.92% | – |
| MNST | Exit | MONSTER BEVERAGE CORP NEW | $0 | – | -1,143,700 | -100.0% | -2.13% | – |
| PWR | Exit | QUANTA SVCS INC | $0 | – | -1,163,015 | -100.0% | -2.58% | – |
| ADI | Exit | ANALOG DEVICES INC | $0 | – | -819,310 | -100.0% | -2.79% | – |
| ADBE | Exit | ADOBE SYSTEMS INCORPORATED | $0 | – | -392,207 | -100.0% | -4.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.